Those Who Suffer Much, Know Much 2010 - User Control Panel

This low dose naltrexone story is compellingand should be freely shared forwardDr Bernard Bihari’s groundbreaking clinical work with low doses of naltrexone(LDN) commenced over twenty years ago in the late 1980s, but it was not untilthe birth of the internet that a small, but growing number of physicians learnedof and began prescribing low doses of naltrexone (LDN) to minimizeprogression and symptoms of immune system diseases for their patients.Bihari first successfully treated HIV patients, then Multiple Sclerosis (MS) andCancer patients with low doses of between 3mg and 4.5mg of naltrexone. Inthe ensuing years LDN has been cited as beneficial across a broader spectrumof known or suspected immune system diseases, such as; Crohn’s Disease,Fibromyalgia, Hepatitis B and C, Arthritis, Chronic Fatigue, Parkinson’s Diseaseand a still growing list of others.If you’re wondering how all these diseases are linked, look no further than anerrant immune system.Whilst commercial interests continue to differentiate disease states, with eachyear seeing an increase in the number of apparently disparate diagnoses(based on different lists of symptoms), the breadth of favourable responses toLDN is teaching us something very different, something very important; thatthe range of diseases and conditions responding to LDN is indicating they havemuch more in common than not.Early Adopter AdvocatesRecognizing the potential of this treatment, a handful of professionals haveadopted it to benefit their patients: In Ireland, Dr Pat Crowley has beenprescribing LDN successfully for years, as has Dr Edmond O’Flaherty. Dr BobLawrence in England, himself an MS sufferer, and Dr Tom Gilhooly in Scotlandhave long been prescribing LDN, with success, to treat their MS patients.In the USA, Dr Jaquelyn McCandless discovered LDN could benefit Autism,which prompted Dr Tyrus Smith of Coastal Compounding to develop the firstLDN topical formulation - a cream comprising emu oil and naltrexone that’sapplied to the fine skin on the inside wrist, to bypass digestive issues. Dr TyrusSmith has since shared his LDN topical formulation with other compoundingpharmacists around the world, in the best interest of helping sufferersworldwide.Dr McCandless has also generously donated her time, expertise, and money. In2006 she travelled to Mali, Africa with her husband Jack Zimmerman to initiatea (soon to be published) LDN trial for HIV that was also generously supportedby a band of LDN advocates. Case Health Pty LtdRevised – July 2007, July 2008, July 2009, July 2010Page 10/433